179 related articles for article (PubMed ID: 35012455)
1. GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism.
Wu YC; Chen CI; Chen PY; Kuo CH; Hung YH; Peng KY; Wu VC; Tsai-Wu JJ; Hsu CL;
BMC Bioinformatics; 2022 Jan; 22(Suppl 10):613. PubMed ID: 35012455
[TBL] [Abstract][Full Text] [Related]
2. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
[TBL] [Abstract][Full Text] [Related]
3. A Chinese pedigree with glucocorticoid remediable aldosteronism.
Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J
Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604
[TBL] [Abstract][Full Text] [Related]
4. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS
J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686
[TBL] [Abstract][Full Text] [Related]
5. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
Carvajal CA; Campino C; Martinez-Aguayo A; Tichauer JE; Bancalari R; Valdivia C; Trejo P; Aglony M; Baudrand R; Lagos CF; Mellado C; Garcia H; Fardella CE
Hypertension; 2012 Jan; 59(1):85-91. PubMed ID: 22083159
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production.
Nicod J; Dick B; Frey FJ; Ferrari P
Mol Cell Endocrinol; 2004 Feb; 214(1-2):167-74. PubMed ID: 15062555
[TBL] [Abstract][Full Text] [Related]
7. A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I.
Carvajal CA; Stehr CB; González PA; Riquelme EM; Montero T; Santos MJ; Kalergis AM; Fardella CE
J Endocrinol Invest; 2011 Feb; 34(2):140-4. PubMed ID: 20634641
[TBL] [Abstract][Full Text] [Related]
8. Chimeric CYP11B2/CYP11B1 causing 11β-hydroxylase deficiency in Chinese patients with congenital adrenal hyperplasia.
Xu L; Xia W; Wu X; Wang X; Zhao L; Nie M
Steroids; 2015 Sep; 101():51-5. PubMed ID: 26066897
[TBL] [Abstract][Full Text] [Related]
9. Improving the diagnosis of 11β-hydroxylase deficiency using home-made MLPA probes: identification of a novel chimeric CYP11B2/CYP11B1 gene in a Sicilian patient.
Menabò S; Boccassini S; Gambineri A; Balsamo A; Pasquali R; Prontera O; Mazzanti L; Baldazzi L
J Endocrinol Invest; 2016 Mar; 39(3):291-5. PubMed ID: 26280318
[TBL] [Abstract][Full Text] [Related]
10. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.
Adler G; Widecka K; Peczkowska M; Dobrucki T; Placha G; Drozd R; Parczewski M; Januszewicz A; Gaciong Z; Ciechanowicz A
J Appl Genet; 2005; 46(3):329-32. PubMed ID: 16110193
[TBL] [Abstract][Full Text] [Related]
11. Unequal crossing over between CYP11B2 and CYP11B1 causes 11 β -hydroxylase deficiency in a consanguineous family.
Xiong Y; Zeng Z; Liang T; Yang P; Lu Q; Yang J; Zhang J; Fang W; Luo P; Hu Y; Zhang M; Zhou D
J Steroid Biochem Mol Biol; 2023 Oct; 233():106375. PubMed ID: 37572761
[TBL] [Abstract][Full Text] [Related]
12. Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism.
MacConnachie AA; Kelly KF; McNamara A; Loughlin S; Gates LJ; Inglis GC; Jamieson A; Connell JM; Haites NE
J Clin Endocrinol Metab; 1998 Dec; 83(12):4328-31. PubMed ID: 9851772
[TBL] [Abstract][Full Text] [Related]
13. A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism.
Ise T; Shimoda A; Takakuwa H; Kato T; Izumiya Y; Shimizu K; Suzuki T; Sasano H; Yokoyama H; Kobayashi K
Clin Endocrinol (Oxf); 2001 Jul; 55(1):131-4. PubMed ID: 11453962
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
Kamrath C; Maser-Gluth C; Haag C; Schulze E
Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
[TBL] [Abstract][Full Text] [Related]
17. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
18. Preclinical diagnosis and identification of the chimeric CYP11B1/CYP11B2 gene in two pediatric cases of a Japanese family with glucocorticoid-remediable aldosteronism.
Nakano Y; Iwata N; Ogura-Ochi K; Hasegawa K; Hirasawa A; Otsuka F
Hypertens Res; 2021 Jul; 44(7):891-893. PubMed ID: 33642567
[No Abstract] [Full Text] [Related]
19. Detection of Small
Xie H; Yin H; Ye X; Liu Y; Liu N; Zhang Y; Chen X; Chen X
Front Endocrinol (Lausanne); 2022; 13():882863. PubMed ID: 35685215
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism.
Takeda Y; Furukawa K; Inaba S; Miyamori I; Mabuchi H
J Clin Endocrinol Metab; 1999 May; 84(5):1633-7. PubMed ID: 10323392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
